The NHS has issued a cautionary note on its website for those taking metformin, particularly those who have been on the ...

The NHS has a word of warning on its website for anyone who is taking metformin, though it is especially aimed at people who ...

A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting that ...

Vitamin B12 plays a crucial role in maintaining a healthy nervous system; its deficiency can lead to nerve damage, resulting ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...

Eli Lilly's experimental oral weight-loss drug, orforglipron, demonstrated superior blood sugar control in diabetic patients ...

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.

Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials.

Eli Lilly (LLY) stock is in focus as the company's oral weight loss candidate orforglipron succeeds in two Phase 3 trials for ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...